(Q40085786)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28826284%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

title

Middle East respiratory syndrome coronavirus: five years later (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28826284%20AND%20SRC:MED&resulttype=core&format=json

Middle East respiratory syndrome coronavirus

28 March 2020

main subject

0 references

Middle East

0 references

Middle East respiratory syndrome

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28826284%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

author name string

Ali A Rabaan

series ordinal

1

1 reference

17 September 2017

publication date

21 August 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28826284%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Respiratory Medicine

28 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28826284%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28826284%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28826284%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

page(s)

901-912

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28826284%20AND%20SRC:MED&resulttype=core&format=json

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

28 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Identifying determinants of heterogeneous transmission dynamics of the Middle East respiratory syndrome (MERS) outbreak in the Republic of Korea, 2015: a retrospective epidemiological analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Objective Determination of End of MERS Outbreak, South Korea, 2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Rooting the phylogenetic tree of middle East respiratory syndrome coronavirus by characterization of a conspecific virus from an African bat

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Characterization of a novel betacoronavirus related to middle East respiratory syndrome coronavirus in European hedgehogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Viral Load Kinetics of MERS Coronavirus Infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Transmission and evolution of the Middle East respiratory syndrome coronavirus in Saudi Arabia: a descriptive genomic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Spread, circulation, and evolution of the Middle East respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Middle East Respiratory Syndrome Infection Control and Prevention Guideline for Healthcare Facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Tropism and replication of Middle East respiratory syndrome coronavirus from dromedary camels in the human respiratory tract: an in-vitro and ex-vivo study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Active replication of Middle East respiratory syndrome coronavirus and aberrant induction of inflammatory cytokines and chemokines in human macrophages: implications for pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

2014 MERS-CoV outbreak in Jeddah--a link to health care facilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Family cluster of Middle East respiratory syndrome coronavirus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Presentation and outcome of Middle East respiratory syndrome in Saudi intensive care unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

MERS coronavirus: diagnostics, epidemiology and transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Evolutionary Dynamics of MERS-CoV: Potential Recombination, Positive Selection and Transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

An update on Middle East respiratory syndrome: 2 years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Origin and Possible Genetic Recombination of the Middle East Respiratory Syndrome Coronavirus from the First Imported Case in China: Phylogenetics and Coalescence Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Spread of MERS to South Korea and China

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Comparative epidemiology of Middle East respiratory syndrome coronavirus (MERS-CoV) in Saudi Arabia and South Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Infection control and prevention practices implemented to reduce transmission risk of Middle East respiratory syndrome-coronavirus in a tertiary care institution in Saudi Arabia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Outbreak of Middle East Respiratory Syndrome at Tertiary Care Hospital, Jeddah, Saudi Arabia, 2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Preventing healthcare-associated transmission of the Middle East Respiratory Syndrome (MERS): Our Achilles heel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Transmission of Middle East Respiratory Syndrome Coronavirus Infections in Healthcare Settings, Abu Dhabi

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Characteristics and Outcomes of Middle East Respiratory Syndrome Coronavirus Patients Admitted to an Intensive Care Unit in Jeddah, Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Patient characteristics infected with Middle East respiratory syndrome coronavirus infection in a tertiary hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Human-Dromedary Camel Interactions and the Risk of Acquiring Zoonotic Middle East Respiratory Syndrome Coronavirus Infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Risk Factors for Primary Middle East Respiratory Syndrome Coronavirus Illness in Humans, Saudi Arabia, 2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Occupational Exposure to Dromedaries and Risk for MERS-CoV Infection, Qatar, 2013-2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Evidence for camel-to-human transmission of MERS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Cross-sectional surveillance of Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels and other mammals in Egypt, August 2015 to January 2016

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels in Nigeria, 2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Geographic distribution of MERS coronavirus among dromedary camels, Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

High proportion of MERS-CoV shedding dromedaries at slaughterhouse with a potential epidemiological link to human cases, Qatar 2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Serologic Evidence for MERS-CoV Infection in Dromedary Camels, Punjab, Pakistan, 2012-2015

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

MERS-CoV Antibodies in Humans, Africa, 2013-2014.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

MERS-CoV at the Animal-Human Interface: Inputs on Exposure Pathways from an Expert-Opinion Elicitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Infectivity of an Asymptomatic Patient With Middle East Respiratory Syndrome Coronavirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Middle East respiratory syndrome coronavirus infection mediated by the transmembrane serine protease TMPRSS2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Role of the spike glycoprotein of human Middle East respiratory syndrome coronavirus (MERS-CoV) in virus entry and syncytia formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Two Mutations Were Critical for Bat-to-Human Transmission of Middle East Respiratory Syndrome Coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

MERS-CoV vaccine candidates in development: The current landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Two deletion variants of Middle East respiratory syndrome coronavirus found in a patient with characteristic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

The heptad repeat region is a major selection target in MERS-CoV and related coronaviruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

A Comparative Review of Animal Models of Middle East Respiratory Syndrome Coronavirus Infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Coronavirus Host Range Expansion and Middle East Respiratory Syndrome Coronavirus Emergence: Biochemical Mechanisms and Evolutionary Perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Glycosylation of mouse DPP4 plays a role in inhibiting Middle East respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Update on therapeutic options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Coronaviruses - drug discovery and therapeutic options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Middle East respiratory syndrome vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Middle East Respiratory Syndrome Virus Pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Combination therapy with lopinavir/ritonavir, ribavirin and interferon-α for Middle East respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Hyperimmune IV immunoglobulin treatment: a multicenter double-blind randomized controlled trial for patients with severe 2009 influenza A(H1N1) infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Feasibility of a randomized controlled trial to assess treatment of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection in Saudi Arabia: a survey of physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Feasibility, safety, clinical, and laboratory effects of convalescent plasma therapy for patients with Middle East respiratory syndrome coronavirus infection: a study protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Clinical and laboratory findings of the first imported case of Middle East respiratory syndrome coronavirus to the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

MERS-CoV spike protein: a key target for antivirals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Exceptionally potent neutralization of Middle East respiratory syndrome coronavirus by human monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Passive Transfer of A Germline-like Neutralizing Human Monoclonal Antibody Protects Transgenic Mice Against Lethal Middle East Respiratory Syndrome Coronavirus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)-Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Potent neutralization of MERS-CoV by human neutralizing monoclonal antibodies to the viral spike glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Structural basis for the neutralization of MERS-CoV by a human monoclonal antibody MERS-27

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

A humanized neutralizing antibody against MERS-CoV targeting the receptor-binding domain of the spike protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Rapid generation of a human monoclonal antibody to combat Middle East respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

3B11-N, a monoclonal antibody against MERS-CoV, reduces lung pathology in rhesus monkeys following intratracheal inoculation of MERS-CoV Jordan-n3/2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Evaluation of candidate vaccine approaches for MERS-CoV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Toward Developing a Preventive MERS-CoV Vaccine-Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14-15, 2015.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Systemic and mucosal immunity in mice elicited by a single immunization with human adenovirus type 5 or 41 vector-based vaccines carrying the spike protein of Middle East respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

An orthopoxvirus-based vaccine reduces virus excretion after MERS-CoV infection in dromedary camels

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

One-Health: a Safe, Efficient, Dual-Use Vaccine for Humans and Animals against Middle East Respiratory Syndrome Coronavirus and Rabies Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

A synthetic consensus anti-spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Novel chimeric virus-like particles vaccine displaying MERS-CoV receptor-binding domain induce specific humoral and cellular immune response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

MERS coronavirus in dromedary camel herd, Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Immunogenicity of Candidate MERS-CoV DNA Vaccines Based on the Spike Protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Protease inhibitors targeting coronavirus and filovirus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Thiopurine analogs and mycophenolic acid synergistically inhibit the papain-like protease of Middle East respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

X-ray Structure and Enzymatic Activity Profile of a Core Papain-like Protease of MERS Coronavirus with utility for structure-based drug design

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 Is an Important Surface Attachment Factor That Facilitates Entry of Middle East Respiratory Syndrome Coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

Towards improving clinical management of Middle East respiratory syndrome coronavirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F17476348.2017.1367288

10.1080/17476348.2017.1367288

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28826284%20AND%20SRC:MED&resulttype=core&format=json

28 March 2020

1 reference